Literature DB >> 30368410

Successful Treatment with Osimertinib and Chemotherapy in a Non-Small Cell Lung Cancer Patient with EGFR Mutation and Meningeal Carcinomatosis.

Hironori Yoshida1, Masahiro Ooi1, Young Hak Kim2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30368410     DOI： 10.1016/j.jtho.2018.05.023

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

1.  Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes.

Authors:  A Cortellini; A Leonetti; A Catino; P Pizzutillo; B Ricciuti; A De Giglio; R Chiari; P Bordi; D Santini; R Giusti; M De Tursi; D Brocco; F Zoratto; F Rastelli; F Citarella; M Russano; M Filetti; P Marchetti; R Berardi; M Torniai; D Cortinovis; E Sala; C Maggioni; A Follador; M Macerelli; O Nigro; A Tuzi; D Iacono; M R Migliorino; G Banna; G Porzio; K Cannita; M G Ferrara; E Bria; D Galetta; C Ficorella; M Tiseo
Journal:  Clin Transl Oncol       Date:  2019-08-07       Impact factor: 3.405

2.  Heterogeneity or transformation? A whack-a-mole case of EGFR-mutant lung adenocarcinoma and small cell carcinoma: A case report.

Authors:  Taira Ninomaru; Akito Hata; Shigeo Hara; Masato Komatsu
Journal:  Thorac Cancer       Date:  2022-07-06       Impact factor: 3.223
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.